A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion. - Sharma, Shashikant; RE-ENACT 2 Study Investigators Group; Anandkumar, Manjunath Bhaskar; Jain, Sangita; Murthy, Hemanth; Murlidhar, Naveenam Srinivasa; Hirawat, Raj Shri; Sudhalkar, Aditya; Deka, Amarendra; Banker, Alay; Parikh, Vatsal; Agarwal, Manisha; et al. (Ophthalmology & Therapy, 2020)